Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06352840
Other study ID # HUM00231526
Secondary ID 5K23HD099283-03
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 2024
Est. completion date April 2026

Study information

Verified date April 2024
Source University of Michigan
Contact Jordyn Boggan
Phone 269-760-7317
Email jboggan@umich.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study is being completed to evaluate the effectiveness of a web-based, self-management program for patients with Chronic Pelvic Pain (CPP). The overall hypothesis is that patients with chronic pelvic pain that have access to the My Pelvic Plan program will demonstrate improvements in pain, physical function, and quality of life with this integrative self-management approach.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 125
Est. completion date April 2026
Est. primary completion date April 2026
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Participants have chronic pelvic pain, defined by the protocol for = 6-month duration, and is non-cyclic, occurring for at least 14 days of each month. - Must be currently receiving care within Department of Obstetrics and Gynecology at the University of Michigan for treatment of chronic pelvic pain - Access to internet via computer or smartphone - English-language proficiency (current version of the website is in English) Exclusion Criteria: - Underwent gynecologic surgery within 3 months of screening visit - Plan to undergo gynecologic surgery within 6 months following screening visit - Pregnant (self-reported) at time of screening visit. Will not exclude patients that become pregnant during the course of the study. - Currently undergoing cognitive behavioral therapy (in-person or virtual, conducted with a therapist) at time of screening visit - Severe physical impairment precluding participating in internet-based program (for example, complete blindness or deafness) - Current psychiatric disorder with history of psychosis (for example, schizophrenia, schizoaffective disorder, delusional disorder), - Current suicidal ideation or suicide attempt within 2 years of screening visit. The study will screen for severe depression and suicidality at each questionnaire time point and have developed a robust triage and referral plan.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
My Pelvic Plan Website
This is a self-directed program which integrates patient education about conditions that frequently contribute to pelvic pain, as well as instruction on cognitive and behavioral restructuring, self-administration of acupressure, engaging in physical activity, and a brief introduction to pelvic floor physical therapy techniques. Participants will have open access to the program over the 6-month intervention period. The intervention will be comprised of an active (12-week) phase and a maintenance (3-month) phase. Participants will receive a weekly text or email prompt directing patients to a specific module. All participants will receive prompts to the same modules for the first four weeks of the study, then during the next 8 weeks, participants will receive prompts to modules that corresponded to the most impactful symptoms on participant's baseline questionnaires. Following 12-week active phase, all participants will enter the maintenance phase.
Control Group website
Patients in the control group will undergo an active control intervention in which participants receive open access to a separate website that contains only the Monitoring Progress symptom tracker subpage over the 6-month study period. Control group participation will also be divided into an active (12-week) phase and a maintenance (3-month) phase. Similar to the intervention group, the control group will receive a weekly text (first 12 weeks) or email prompt directing them to a specific module or portion of the respective website. During the maintenance phase of the study, participants will receive monthly prompts to the Monitoring Progress subpage (without prompting to a specific symptom or activity).

Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan

Sponsors (2)

Lead Sponsor Collaborator
University of Michigan Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient Reported Outcomes Measurement Information System (PROMIS) Pain Interference short form (SF) 4a between groups There are four questions that participants will answer from not at all (1) - very much (5). Scores range from 4-20, with higher scores meaning more interference. 3 months
Primary PROMIS pain intensity 1a between groups There is one question that participants will answer no pain (0) - worst pain (10). Lower score means less pain. 3 months
Primary PROMIS Self Efficacy for Managing Symptoms SF 4a between groups There are four questions that participants will answer from I am not all confident (1) - I am very confident (5). Scores range from 4-20, with higher scores meaning more confident. 3 months
Secondary Patient Reported Outcomes Measurement Information System (PROMIS) Pain Interference short form (SF) 4a between groups There are four questions that participants will answer from not at all (1) - very much (5). Scores range from 4-20, with higher scores meaning more interference. 6 months
Secondary PROMIS pain intensity 1a between groups There is one question that participants will answer no pain (0) - worst pain (10). Lower score means less pain. 6 months
Secondary PROMIS Self Efficacy for Managing Symptoms SF 4a between groups There are four questions that participants will answer from I am not all confident (1) - I am very confident (5). Scores range from 4-20, with higher scores meaning more confident. 6 months
See also
  Status Clinical Trial Phase
Completed NCT01931670 - A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain Phase 3
Recruiting NCT05648669 - A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain Phase 3
Recruiting NCT04081532 - The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain N/A
Recruiting NCT06101303 - Endometriosis Pain
Completed NCT04665414 - Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
Completed NCT03690765 - Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
Recruiting NCT05153512 - ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)
Active, not recruiting NCT04171297 - Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
Recruiting NCT04172272 - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures N/A
Recruiting NCT04565470 - Strategies of Self-management of Endometriosis Symptoms
Completed NCT03613298 - Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement. N/A
Not yet recruiting NCT05568940 - Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
Not yet recruiting NCT03464799 - Does Immunotherapy Have a Role in the Management of Endometriosis?
Active, not recruiting NCT03002870 - Characteristics of Patient Population With Endometriosis N/A
Withdrawn NCT03272360 - Endometriosis Biomarker Discovery Study N/A
Completed NCT02973854 - Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
Recruiting NCT02481739 - Laparoscopic Surgical Management of Endometriosis on Fertility N/A
Active, not recruiting NCT02754648 - Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve N/A
Completed NCT06106932 - GnRH-a on Angiogenesis of Endometriosis N/A
Completed NCT02387931 - Supplementation in Adolescent Girls With Endometriosis Phase 4